Prem S. Shah - Apr 1, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Prem S. Shah
Stock symbol
CVS
Transactions as of
Apr 1, 2023
Transactions value $
$6,379,662
Form type
4
Date filed
4/4/2023, 04:36 PM
Previous filing
Mar 1, 2023
Next filing
Sep 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$239K -3.22K -6.13% $74.31 49.4K Apr 1, 2023 Direct F1
holding CVS Common Stock (pep) 4.52K Apr 1, 2023 Direct
holding CVS Common Stock (Restricted) 29.6K Apr 1, 2023 Direct
holding CVS ESOP Common Stock 4.67K Apr 1, 2023 Direct
holding CVS Stock Unit (deferred) 7.76K Apr 1, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $6.62M +89.1K $74.31 89.1K Apr 1, 2023 Common Stock 89.1K $74.31 Direct F12
holding CVS Phantom Stock Credits 12.2K Apr 1, 2023 Common Stock 12.2K $1.00 Direct F3, F4
holding CVS Stock Option 2.94K Apr 1, 2023 Common Stock 2.94K $104.82 Direct F5
holding CVS Stock Option 846 Apr 1, 2023 Common Stock 846 $62.21 Direct F6
holding CVS Stock Option 9.47K Apr 1, 2023 Common Stock 9.47K $54.19 Direct F7
holding CVS Stock Option 28.6K Apr 1, 2023 Common Stock 28.6K $58.34 Direct F8
holding CVS Stock Option 26.6K Apr 1, 2023 Common Stock 26.6K $75.24 Direct F9
holding CVS Stock Option 28.7K Apr 1, 2023 Common Stock 28.7K $74.30 Direct F10
holding CVS Stock Option 41.6K Apr 1, 2023 Common Stock 41.6K $101.09 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
F2 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5 Option became exercisable in four equal installments commencing 04/01/2017.
F6 Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F7 Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
F8 Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F9 Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.
F10 Option became exercisable in three equal installments commencing 04/01/2022.
F11 Option became exercisable in four equal installments, commencing 4/1/2023.
F12 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.